Ms. Meredith Lyn Wilkinson, ED.S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 953 Davis Hwy, Mineral, VA 23117 Phone: 540-894-5115 Fax: 540-894-0252 |
Mrs. Kathryn B Wash, ED.S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 953 Davis Hwy, Mineral, VA 23117 Phone: 540-894-5115 Fax: 540-967-0337 |
Sloan Smith Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 953 Davis Hwy, Mineral, VA 23117 Phone: 540-894-5115 |
Ms. Paula Parkhurst Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 953 Davis Hwy, Mineral, VA 23117 Phone: 540-894-5115 Fax: 540-894-5096 |
Renee Mcadams, ED.S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 953 Davis Hwy, Mineral, VA 23117 Phone: 540-894-5115 |
Elizabeth English Harris Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 953 Davis Hwy, Mineral, VA 23117 Phone: 540-894-5115 |
Kelsey C. Beard Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 953 Davis Hwy, Mineral, VA 23117 Phone: 540-894-5115 |
News Archive
It's like the Superman of viruses, astonishingly tough and able to survive in an environment that would dissolve flesh and bone. And now scientists have unlocked the secrets of its indestructibility, potentially allowing them to harness its remarkable properties to create super-durable materials and better treat disease.
Receptors in the brain that are highly sensitive to alcohol may function differently in a person with a family history of alcoholism, according to a Yale study published this month.
Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc.
Genetic research that will be published tomorrow in the New England Journal of Medicine suggests to Dr. André Lacroix, professor at the University of Montreal, that clinicians' understanding and treatment of a form of Cushing's syndrome affecting both adrenal glands will be fundamentally changed, and that moreover, it might be appropriate to begin screening for the genetic mutations that cause this form of the disease.
A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease.
› Verified 4 days ago